Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center

Effectiveness and Tolerability of A Polymyxin B Dosing Protocol

(2012) Diana Esaian et al.   ANNALS OF PHARMACOTHERAPY

Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy

(2012) Christine J. Kubin et al.   JOURNAL OF INFECTION

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System

(2011) J. M. Pogue et al.   CLINICAL INFECTIOUS DISEASES

Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients

(2011) Neha M Doshi et al.   PHARMACOTHERAPY

Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital

(2010) C. A. DeRyke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and Risk Factors for Acute Kidney Injury Associated with Parenteral Polymyxin B Use

(2009) Carlos AC Mendes et al.   ANNALS OF PHARMACOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity

(2009) Maura S. Oliveira et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Definition and Classification of Acute Kidney Injury

(2008) John A. Kellum et al.   NEPHRON CLINICAL PRACTICE

Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria

(2007) Christine B. Teng et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS